Statistics

Total Visits

Views
BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)81

Select a period of time:

Number of views in the range

Views
BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)19

Views

Views
October 20250
November 20252
December 20250
January 202612
February 20262
March 20263
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Finland2
Angola1
Argentina1
Brazil1
Ecuador1
Peru1
Slovakia1
 

Top cities views

Views
San Jose10
Helsinki2
Chiclayo1
Manta1
Mendoza1
Námestovo1
Pelotas1